Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (531-540 of 1,253) with videos related to

Pageof 126
Sort By:
Journal of Medical Economics|April 8, 2014
The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS studyKevin R Bainey, Amiram Gafni, Purnima Rao-Melacini, et al.
Journal of the American College of Cardiology|February 7, 2025
Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUSManasi Tannu, Renato D Lopes, Daniel M Wojdyla, et al.
The American Journal of Cardiology|December 1, 2001
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-TrialB G Angeja, J H Alexander, R Chin, et al.
Heart (British Cardiac Society)|February 28, 2009
Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary EventsD Brieger, K A A Fox, G Fitzgerald, et al.
American Heart Journal|March 20, 2012
Development and validation of a prioritization rule for obtaining an immediate 12-lead electrocardiogram in the emergency department to identify ST-elevation myocardial infarctionSeth W Glickman, Frances S Shofer, Michael C Wu, et al.
Journal of the American College of Cardiology|March 27, 2001
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromesM C Bahit, E J Topol, R M Califf, et al.
Circulation|November 3, 1998
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb InvestigatorsP W Armstrong, Y Fu, W C Chang, et al.
Archives of Internal Medicine|July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trialJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.
Journal of the American Heart Association|March 26, 2024
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE TrialKonstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, et al.
Pageof 126

Showing results (531-540 of 1,253) with videos related to

Sort By:
Pageof 126
Journal of Medical Economics|April 8, 2014
The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS studyKevin R Bainey, Amiram Gafni, Purnima Rao-Melacini, et al.
Journal of the American College of Cardiology|February 7, 2025
Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUSManasi Tannu, Renato D Lopes, Daniel M Wojdyla, et al.
The American Journal of Cardiology|December 1, 2001
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-TrialB G Angeja, J H Alexander, R Chin, et al.
Heart (British Cardiac Society)|February 28, 2009
Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary EventsD Brieger, K A A Fox, G Fitzgerald, et al.
American Heart Journal|March 20, 2012
Development and validation of a prioritization rule for obtaining an immediate 12-lead electrocardiogram in the emergency department to identify ST-elevation myocardial infarctionSeth W Glickman, Frances S Shofer, Michael C Wu, et al.
Journal of the American College of Cardiology|March 27, 2001
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromesM C Bahit, E J Topol, R M Califf, et al.
Circulation|November 3, 1998
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb InvestigatorsP W Armstrong, Y Fu, W C Chang, et al.
Archives of Internal Medicine|July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trialJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.
Journal of the American Heart Association|March 26, 2024
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE TrialKonstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, et al.
Pageof 126